Welcome to the
Welcome to the
Oligonucleotide Therapeutics Society
The Oligonucleotide Therapeutics Society (OTS) is an open, nonprofit forum to foster research and development of oligonucleotide therapeutics. The Founders’ vision was to bring together the expertise from different angles of oligonucleotide research to create synergies and to bring the field of oligonucleotides to its full therapeutic potential. A new era of oligonucleotide drugs was envisioned that would change the landscape of therapeutic modalities.
Oligonucleotide therapeutics are now being used to successfully treat diseases and have the potential for widespread application. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. Incredibly, oligonucleotide therapeutics have also been used to create an individualized treatment for one single person with a rare, fatal disease.
All the latest news
FEATURED ARTICLE
Facts about COVID-19 mRNA Vaccines and the Decades of Research That Went into Creating Them
Clinical Trials Begin for Ultra-Rare Treatment of Alexander Disease
There is currently no treatment to slow or halt disease progression, but proactive, comprehensive medical care is helpful for [...]
Looking back… Looking forward
This will be my last contribution that I write as President of our Society. On January 1st, 2022, I [...]
Can an ASO Reduce Disease Progression in ALS?
What if you noticed your body acting a bit “off,” doing something unusual and more than a bit worrying? [...]
Featured Member
Vasant Jadhav, PhD.
SVP Head of RNAi Platform
Alnylam Pharmaceuticals
During undergrad, I was intrigued by the molecular machines and mechanisms behind secrets of life- replication, transcription, and translation. Understanding nature’s language and redirecting it for applied research seemed like super cool idea!
;
